CNTA
Price
$15.41
Change
-$0.07 (-0.45%)
Updated
Jul 25 closing price
Capitalization
2.06B
21 days until earnings call
DNLI
Price
$13.67
Change
-$0.64 (-4.47%)
Updated
Jul 25 closing price
Capitalization
1.99B
3 days until earnings call
Interact to see
Advertisement

CNTA vs DNLI

Header iconCNTA vs DNLI Comparison
Open Charts CNTA vs DNLIBanner chart's image
Centessa Pharmaceuticals
Price$15.41
Change-$0.07 (-0.45%)
Volume$355.82K
Capitalization2.06B
Denali Therapeutics
Price$13.67
Change-$0.64 (-4.47%)
Volume$1.18M
Capitalization1.99B
CNTA vs DNLI Comparison Chart in %
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. DNLI commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Buy and DNLI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (CNTA: $15.41 vs. DNLI: $13.67)
Brand notoriety: CNTA and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 34% vs. DNLI: 77%
Market capitalization -- CNTA: $2.06B vs. DNLI: $1.99B
CNTA [@Biotechnology] is valued at $2.06B. DNLI’s [@Biotechnology] market capitalization is $1.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 5 TA indicator(s) are bullish while DNLI’s TA Score has 3 bullish TA indicator(s).

  • CNTA’s TA Score: 5 bullish, 4 bearish.
  • DNLI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CNTA is a better buy in the short-term than DNLI.

Price Growth

CNTA (@Biotechnology) experienced а -1.78% price change this week, while DNLI (@Biotechnology) price change was -2.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.36%. For the same industry, the average monthly price growth was +22.71%, and the average quarterly price growth was +43.79%.

Reported Earning Dates

CNTA is expected to report earnings on Aug 18, 2025.

DNLI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($2.06B) and DNLI($1.99B) have the same market capitalization . CNTA YTD gains are higher at: -8.000 vs. DNLI (-32.924). CNTA has higher annual earnings (EBITDA): -208.73M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. CNTA (285M). DNLI has less debt than CNTA: DNLI (48.6M) vs CNTA (118M). CNTA has higher revenues than DNLI: CNTA (15M) vs DNLI (0).
CNTADNLICNTA / DNLI
Capitalization2.06B1.99B104%
EBITDA-208.73M-505.16M41%
Gain YTD-8.000-32.92424%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash285M818M35%
Total Debt118M48.6M243%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTADNLI
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCCX22.380.17
+0.77%
MFS Mid Cap Growth C
TIOTX16.600.04
+0.24%
Nuveen International Opps Retire
VLAIX42.400.10
+0.24%
Value Line Asset Allocation Instl
WLIVX18.49-0.06
-0.32%
WCM Focused International Equity Inv
JOPSX14.25-0.11
-0.77%
JOHCM International Opps Institutional

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with NRIX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-0.45%
NRIX - CNTA
47%
Loosely correlated
-0.09%
CRNX - CNTA
46%
Loosely correlated
+1.91%
XENE - CNTA
44%
Loosely correlated
-2.29%
DNLI - CNTA
42%
Loosely correlated
-4.47%
IMCR - CNTA
42%
Loosely correlated
-0.28%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-4.47%
BEAM - DNLI
63%
Loosely correlated
+3.68%
NRIX - DNLI
62%
Loosely correlated
-0.09%
IDYA - DNLI
60%
Loosely correlated
-1.33%
RGNX - DNLI
58%
Loosely correlated
-1.86%
ARWR - DNLI
57%
Loosely correlated
-3.20%
More